Atossa Therapeutics
Atossa Therapeutics Logo
About Atossa Therapeutics
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for areas of significant unmet medical need in oncology, with a primary emphasis on breast cancer. Its lead program is oral (Z)-endoxifen, which is in Phase II clinical trials for the treatment and prevention of breast cancer. The company also develops immunotherapy and chimeric antigen receptor therapy programs targeting other oncology indications.
Address
107 Spring Street,
Seattle, 98104
United States
Year founded
2009
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
